Form 4 for TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Accepted 2025-12-04 00:00:00 ET · period of report 2025-12-02 · accession 0001193125-25-308057 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-04 | 2025-12-02 | TEVA | Lichtenstein Chen | Dir | M - OptEx | — | +4,804 | 4,804 | New | — |
| D | 2025-12-04 | 2025-12-02 | TEVA | Lichtenstein Chen | Dir | M - OptEx | $0.00 | -4,804 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-12-02 | M | A | 4,804 | — | 4,804 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. |
| 2 | Derivative | Restricted Share Units | 2025-12-02 | M | D | 4,804 | $0.00 | 0 | D | — · — to — | 4,804 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F3) Restricted share units were granted on December 2, 2024 and vested on December 2, 2025. |